The evaluation of immunotherapy and chemotherapy treatment on melanoma: a network meta-analysis | Zendy

Ba-Sang Ci-Ren | Zendy; Xinhua Wang | Zendy; Ziwen Long | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

The evaluation of immunotherapy and chemotherapy treatment on melanoma: a network meta-analysis

Author(s) -

Ba-Sang Ci-Ren,

Xinhua Wang,

Ziwen Long

Publication year - 2016

Publication title -

oncotarget

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.373

H-Index - 127

ISSN - 1949-2553

DOI - 10.18632/oncotarget.13277

Subject(s) - medicine , meta analysis , oncology , ipilimumab , pembrolizumab , melanoma , randomized controlled trial , chemotherapy , cochrane library , adverse effect , cancer , immunotherapy , dermatology , cancer research

Melanoma is a highly malignant tumor that develops from a neural crest derivative called melanocytes. Chemotherapy is recommended for patients with stage III/IV melanoma. Immunomodulation has also been shown to effectively improve the survival rate of such patients. In the current study, we aimed to perform a network meta-analysis on the therapeutic value of chemotherapy and immunotherapy on melanoma.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research